Gala Therapeutics' RheOx™ System Showcased in Live Case at Virtual European Respiratory Society (ERS) Congress as Part of Post-Market Chronic Bronchitis Study
MENLO PARK, Calif., Sept. 9, 2020 /PRNewswire/ -- Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, today announced that a live case featuring its RheOx™ Bronchial Rheoplasty System was performed during the virtual European Respiratory Society (ERS) International Congress 2020.
The session showcased the endoscopic technique of Bronchial Rheoplasty with RheOx, which delivers non-thermal energy to the airways to reduce mucus-producing cells in patients with chronic bronchitis. Prof. Dr. med. Felix Herth and Prof. Dr. med. Ralf Eberhardt of Thoraxklinik at the University of Heidelberg in Heidelberg, Germany, performed the procedure and described the clinical outcomes, including:
"At Thoraxklinik we have a long history of advancing research and treatments for lung disease to improve the lives of the patients we treat, including an increasing focus on new endoscopic approaches. We are excited to have treated the first patients in Germany with Bronchial Rheoplasty this week," said Univ. Prof. Dr. med. Felix Herth, Medical Director of the Department for Internal Medicine and Pneumology at Thoraxklinik in Heidelberg. "There are no good treatment options for chronic bronchitis, so we are very hopeful that Bronchial Rheoplasty will make a meaningful difference in quality-of-life for these patients."
The case was part of the Gala Therapeutics post-market study, which aims to collect real-world clinical experience in up to 20 European centers on the performance, safety and efficacy of Bronchial Rheoplasty in up to 100 adult patients with moderate to severe chronic bronchitis.
"We are honored to spotlight Bronchial Rheoplasty at ERS, one of the world's largest medical congresses for respiratory disease, and to engage additional caregivers in our post-market study," said Jonathan Waldstreicher, MD, CEO of Gala Therapeutics. "We look forward to continuing to build the clinical evidence for this therapy."
View live case session at https://ers.conference2web.com/#!resources/rheoplasty-bronchitis
About Gala Therapeutics
View original content to download multimedia:http://www.prnewswire.com/news-releases/gala-therapeutics-rheox-system-showcased-in-live-case-at-virtual-european-respiratory-society-ers-congress-as-part-of-post-market-chronic-bronchitis-study-301126421.html
SOURCE Gala Therapeutics